Manufacturer record
Mayoford Pharma Near Railway Crossing: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Mayoford Pharma Near Railway Crossing (Himachal Pradesh) was declared Not of Standard Quality in October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MMT-9435, Stenflam SP (exp Jan 2026). MDTL Kathua,Jammu and Kashmir (state lab) found it not of standard quality: The sample fails in the Assay contents of Paracetamol. Listed in the October 2025 alert.
Records by type
1 record linked to Mayoford Pharma Near Railway Crossing in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Stenflam SP | Batch MMT-9435Mfg Feb 2024 · Exp Jan 2026 | The sample fails in the Assay contents of Paracetamol.Assay | MDTL Kathua,Jammu and KashmirState lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.